Haploidentical Stem Cell Transplantation With Dual Source of Cells and Post‐Transplant Cyclophosphamide
ABSTRACT Background Dual sources of cells (DSC) with peripheral blood stem cell apheresis (PBSC) and surgical bone marrow (BM) for haploidentical hematopoietic cell transplantation (Hid‐HCT) are used in China and some Asian countries. The experience of the Baltimore group for haploidentical transpla...
Saved in:
Main Authors: | Ana Marcela Rojas Fonseca‐Hial, Katya Parisio, Jose Salvador Rodrigues deOliveira |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-02-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.70541 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Natural Killer (NK) Cell Alloreactivity in Haploidentical Stem Cell Transplantation
by: Mar Luis-Hidalgo, et al.
Published: (2025-07-01) -
How to reduce the risk of primary engraftment failure after haploidentical hematopoietic stem cell transplantation in patients with acute myeloid leukemia?
by: D. K. Zhogolev, et al.
Published: (2025-03-01) -
Impact of graft-versus-host disease prophylaxis on immune reconstitution in patients after allogeneic hematopoietic stem cell transplantation
by: E. D. Mikhaltsova, et al.
Published: (2021-11-01) -
Impact of post-transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing T-cell replete haploidentical bone marrow transplantation: results from a phase Ia/Ib clinical trial
by: Forrest L. Baker, et al.
Published: (2025-04-01) -
Correction: Impact of post-transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing T-cell replete haploidentical bone marrow transplantation: results from a phase Ia/Ib clinical trial
by: Forrest L. Baker, et al.
Published: (2025-06-01)